MederiAI specializes in developing cutting-edge AI detection software tailored for healthcare professionals, specifically designed to analyze footage captured by endoscopy pills. Our software leverages deep learning algorithms to swiftly and accurately identify anomalies within the gastrointestinal (GI) tract, condensing lengthy video recordings into key highlights for efficient review by doctors, hospitals, and clinics.
By automating the detection and diagnosis process, our software significantly reduces the time required for video review and minimizes the risk of oversight, saving healthcare providers valuable time and resources. Moreover, if our system detects significant damage, such as the presence of blood, it will promptly notify the responsible physician to facilitate timely intervention. Additionally, our platform allows doctors to seamlessly accept or decline diagnoses generated by the software, facilitating further model training and improvement.
Ultimately, our solution revolutionizes GI diagnostics by harnessing the power of AI to enhance accuracy, streamline workflow, and prevent oversight, ultimately leading to improved patient care and outcomes.
Company Details
- Employees
- 2
- Founded
- -
- Address
- Copenhagen, Copenhagen 2300, Dk
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.mederiai.com
- Keywords
- Copenhagen.
- HQ
- Copenhagen, Copenhagen
Mederiai Questions
Mederiai's website is http://www.mederiai.com
Mederiai's LinkedIn profile is https://dk.linkedin.com/company/mederiai
Mederiai has
2 employees.
View email and phone details for 2
employees at Mederiai.
Mederiai's industry is
Biotechnology Research
Mederiai's top competitors are
Involved,
Dreamplan,
Signal,
Myndoor,
Wavepiston,
Roccai,
Fruity-Ai,
Attender,
Pentimenti.ai,
Goodwings.
Mederiai's categories are Biotechnology Research
Mederiai's founding year is 2024
